Latest Ratios: P/E Ratio -0.7x · EV/EBITDA N/A · ROE -44.4%. (2016–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $7M | $5M | $16M | $17M | $108M | $914M | $723M | $567M | $225M | — | — |
| Enterprise Value | $783M | $781M | $15M | $19M | $106M | $894M | $717M | $562M | $221M | — | — |
| P/E Ratio → | -0.65 | — | — | — | — | — | 59.06 | — | — | — | — |
| P/S Ratio | 0.39 | 0.25 | 0.83 | 0.69 | 3.04 | 20.55 | 17.26 | 23.96 | 490.23 | — | — |
| P/B Ratio | 0.40 | 0.67 | 8.26 | 1.85 | 3.42 | 8.86 | 9.13 | 15.07 | 16.05 | — | — |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 40.69 | 0.77 | 0.77 | 2.99 | 20.09 | 17.11 | 23.77 | 480.90 | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 62.4% | 62.4% | 55.7% | 54.0% | 57.9% | 65.1% | 63.0% | 61.4% | 28.9% | 69.7% | 20.3% |
| Operating Margin | -11.3% | -11.3% | -16.4% | -38.4% | -48.9% | -44.1% | -42.0% | -60.7% | -391.4% | -5.3% | -183.8% |
| Net Profit Margin | -10.6% | -10.6% | -19.0% | -95.0% | -198.0% | -52.6% | 30.1% | -213.2% | -89.8% | -38.9% | -165.2% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -44.4% | -44.4% | -67.3% | -113.4% | -104.2% | -25.7% | 21.6% | -195.4% | -4.3% | -71.6% | — |
| ROA | -19.4% | -19.4% | -27.6% | -80.5% | -84.6% | -19.8% | 12.3% | -92.1% | -3.7% | -40.0% | -206.8% |
| ROIC | -0.4% | -0.4% | -40.9% | -34.3% | -23.1% | -18.9% | -24.8% | -50.3% | -18.0% | -6.3% | -595.0% |
| ROCE | -47.1% | -47.1% | -47.3% | -39.4% | -22.6% | -17.7% | -18.1% | -27.4% | -18.3% | -9.1% | — |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 107.70 | 107.70 | 0.65 | 0.41 | 0.15 | 0.06 | 0.11 | 0.01 | — | 0.07 | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | 107.39 | -0.60 | 0.21 | -0.06 | -0.20 | -0.08 | -0.12 | -0.31 | 0.01 | — |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — | — | — |
| Interest Coverage | — | — | -108.10 | — | — | -678.05 | — | — | -1881.75 | -0.48 | -24.09 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.05 | 2.05 | 0.74 | 1.73 | 3.03 | 5.28 | 3.08 | 4.24 | 12.16 | 2.42 | 0.50 |
| Quick Ratio | 1.13 | 1.13 | 0.47 | 0.86 | 2.22 | 4.55 | 2.45 | 3.08 | 12.03 | 2.04 | 0.14 |
| Cash Ratio | 0.71 | 0.71 | 0.28 | 0.38 | 1.46 | 3.97 | 1.96 | 1.48 | 6.69 | 0.75 | 0.02 |
| Asset Turnover | — | 1.84 | 1.84 | 1.49 | 0.87 | 0.36 | 0.38 | 0.25 | 0.03 | 0.63 | 1.25 |
| Inventory Turnover | 2.45 | 2.45 | 3.65 | 2.74 | 3.50 | 3.09 | 3.17 | 2.12 | 2.65 | 2.30 | 2.35 |
| Days Sales Outstanding | — | 19.80 | 18.43 | 18.38 | 14.93 | 9.14 | 7.94 | 41.14 | 3342.99 | 112.48 | 29.46 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | 22.0% | 3.7% | 0.3% | 0.1% | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | 1.7% | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 3.4% | 0.0% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 22.0% | 3.7% | 3.6% | 0.1% | 0.0% | 0.0% | — | — |
| Shares Outstanding | — | $4M | $4M | $2M | $1M | $1M | $1M | $397494 | $172221 | $166494 | $91745 |
Liquidity and insolvency risk
Based on recent market data, YCBD trades at a price-to-sales multiple of 0.38, which suggests that investors are heavily discounting the company's future revenue potential amidst persistent operating losses and a lack of clear visibility into a return to positive earnings growth in the near term.
The current P/S multiple of 0.38 indicates that the market assigns minimal value to the company's brand equity, likely due to the ongoing contraction in the core CBD wellness segment. This valuation level implies that investors are pricing in a high probability of continued financial distress rather than a turnaround, warranting caution regarding the company's ability to achieve a sustainable growth trajectory.
As reported in quarterly filings, YCBD's ROIC has consistently languished in negative territory, reaching -0.2% in 2026Q2, which highlights a fundamental inability to generate returns on invested capital that exceed the company's cost of capital in the current competitive landscape.
The persistent negative ROIC suggests that capital allocation has been value-destructive, as the company continues to deploy resources into marketing and operations that fail to yield commensurate returns. Investors should monitor whether management can pivot toward a more capital-efficient model, as the current trend indicates a structural erosion of shareholder value.
According to recent financial statements, YCBD's cash conversion cycle has shown extreme volatility, including a negative 14,933-day cycle in 2026Q2, which appears to be driven by anomalous accounts payable spikes rather than genuine improvements in inventory turnover or operational efficiency.
The erratic nature of the cash conversion cycle suggests that the company is managing its working capital through aggressive payment delays rather than sustainable operational improvements. This reliance on stretching payables may indicate underlying liquidity stress and could potentially jeopardize supplier relationships if not addressed through more stable cash management practices.
Based on the 2026Q2 balance sheet, YCBD's quick ratio of 1.59 provides a superficial appearance of liquidity, yet this is undermined by the company's high debt-to-equity profile and the ongoing cash burn that threatens to exhaust remaining reserves in the coming quarters.
While the current ratio of 2.82 might suggest adequate coverage, the reliance on inventory that may face obsolescence risks makes the quick ratio a more critical, yet still concerning, metric. The company's liquidity position appears highly vulnerable to any further revenue shocks, necessitating a close watch on potential financing requirements to maintain basic operational continuity.
The price-to-earnings ratio is frequently misapplied to YCBD, as the company's persistent net losses render the metric meaningless and obscure the underlying cash burn that is the primary driver of the company's current financial risk profile.
Investors should instead focus on the cash burn rate and the sustainability of the DTC revenue model, as these metrics provide a more accurate assessment of the company's survival prospects. Relying on P/E multiples in a loss-making, high-leverage environment like YCBD's can lead to a dangerous underestimation of the insolvency risk inherent in the business model.
Includes 30+ ratios · 10 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying YCBD stock.
cbdMD, Inc.'s current P/E ratio is -0.7x. The historical average is 59.1x.
cbdMD, Inc.'s return on equity (ROE) is -44.4%. The historical average is -67.2%.
Based on historical data, cbdMD, Inc. is trading at a P/E of -0.7x. Compare with industry peers and growth rates for a complete picture.
cbdMD, Inc. has 62.4% gross margin and -11.3% operating margin.